Cheminformatics-Based Drug Design Approach for Identification of Inhibitors Targeting the Characteristic Residues of MMP-13 Hemopexin Domain
Roopa Kothapalli, Asif M. Khan, Basappa et al. · 2010
Read Cheminformatics-Based Drug Design Approach for Identification of Inhibitors Targeting the Characteristic Residues of MMP-13 Hemopexin Domain by Roopa Kothapalli, Asif M. Khan, Basappa et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0012494.txt.
Description
Roopa Kothapalli, Asif Khan, Basappa and colleagues used computer design to find blockers of a cartilage-chewing enzyme, in a 2010 PLOS ONE paper. The enzyme MMP-13 cuts type II collagen, the main protein of joint cartilage, and it is active in osteoarthritis and rheumatoid arthritis but not in healthy adult tissue. That selectivity makes it a tempting drug target.
The team aimed at a side region of the enzyme, its hemopexin domain, whose special residues differ from sister enzymes. Blocking there could spare related enzymes and cut side effects. Computer-first design narrows thousands of candidates to a testable few, saving years of bench screening for arthritis drug hunters.
Catalog record
| CREATOR | Roopa Kothapalli, Asif M. Khan, Basappa et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012494